RPAM
RVNC
Rhenman & Partners Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-701,707
| Closed | -$1.8M | – | 100 |
|
2024
Q2 | $1.8M | Hold |
701,707
| – | – | 0.17% | 79 |
|
2024
Q1 | $3.45M | Buy |
701,707
+225,835
| +47% | +$1.11M | 0.33% | 60 |
|
2023
Q4 | $4.18M | Buy |
475,872
+114,193
| +32% | +$1M | 0.42% | 62 |
|
2023
Q3 | $4.15M | Buy |
361,679
+238,679
| +194% | +$2.74M | 0.45% | 57 |
|
2023
Q2 | $3.11M | Sell |
123,000
-107,000
| -47% | -$2.71M | 0.33% | 66 |
|
2023
Q1 | $7.16M | Sell |
230,000
-208,000
| -47% | -$6.48M | 0.79% | 41 |
|
2022
Q4 | $8.09M | Buy |
438,000
+50,000
| +13% | +$923K | 0.84% | 47 |
|
2022
Q3 | $8.66M | Sell |
388,000
-62,000
| -14% | -$1.38M | 0.91% | 43 |
|
2022
Q2 | $6.22M | Buy |
450,000
+251,642
| +127% | +$3.48M | 0.71% | 48 |
|
2022
Q1 | $3.87M | Buy |
+198,358
| New | +$3.87M | 0.38% | 70 |
|
2021
Q4 | – | Sell |
-320,000
| Closed | -$8.92M | – | 96 |
|
2021
Q3 | $8.92M | Buy |
320,000
+50,000
| +19% | +$1.39M | 0.63% | 51 |
|
2021
Q2 | $8M | Buy |
270,000
+50,000
| +23% | +$1.48M | 0.54% | 62 |
|
2021
Q1 | $6.15M | Hold |
220,000
| – | – | 0.43% | 67 |
|
2020
Q4 | $6.24M | Hold |
220,000
| – | – | 0.51% | 59 |
|
2020
Q3 | $5.53M | Hold |
220,000
| – | – | 0.49% | 61 |
|
2020
Q2 | $5.37M | Hold |
220,000
| – | – | 0.58% | 60 |
|
2020
Q1 | $3.26M | Sell |
220,000
-30,000
| -12% | -$444K | 0.46% | 62 |
|
2019
Q4 | $4.06M | Buy |
250,000
+76,083
| +44% | +$1.23M | 0.44% | 68 |
|
2019
Q3 | $2.26M | Sell |
173,917
-19,264
| -10% | -$250K | 0.28% | 72 |
|
2019
Q2 | $2.51M | Hold |
193,181
| – | – | 0.28% | 70 |
|
2019
Q1 | $3.05M | Hold |
193,181
| – | – | 0.36% | 68 |
|
2018
Q4 | $3.89M | Sell |
193,181
-10,000
| -5% | -$201K | 0.44% | 62 |
|
2018
Q3 | $5.05M | Hold |
203,181
| – | – | 0.51% | 63 |
|
2018
Q2 | $5.58M | Hold |
203,181
| – | – | 0.57% | 59 |
|
2018
Q1 | $6.26M | Buy |
203,181
+20,601
| +11% | +$635K | 0.77% | 49 |
|
2017
Q4 | $6.53M | Sell |
182,580
-63,820
| -26% | -$2.28M | 0.88% | 47 |
|
2017
Q3 | $6.79M | Buy |
246,400
+26,400
| +12% | +$727K | 0.87% | 45 |
|
2017
Q2 | $5.81M | Buy |
220,000
+10,000
| +5% | +$264K | 0.83% | 47 |
|
2017
Q1 | $4.37M | Hold |
210,000
| – | – | 0.69% | 54 |
|
2016
Q4 | $4.35M | Hold |
210,000
| – | – | 0.83% | 47 |
|
2016
Q3 | $3.4M | Sell |
210,000
-10,000
| -5% | -$162K | 0.54% | 65 |
|
2016
Q2 | $2.99M | Buy |
220,000
+50,000
| +29% | +$680K | 0.53% | 63 |
|
2016
Q1 | $2.97M | Sell |
170,000
-3,000
| -2% | -$52.4K | 0.59% | 61 |
|
2015
Q4 | $5.91M | Buy |
173,000
+25,000
| +17% | +$854K | 0.89% | 44 |
|
2015
Q3 | $4.4M | Sell |
148,000
-24,000
| -14% | -$714K | 0.7% | 55 |
|
2015
Q2 | $5.5M | Sell |
172,000
-64,000
| -27% | -$2.05M | 0.66% | 49 |
|
2015
Q1 | $4.89M | Buy |
236,000
+109,426
| +86% | +$2.27M | 0.82% | 42 |
|
2014
Q4 | $2.14M | Buy |
126,574
+21,319
| +20% | +$361K | 0.62% | 71 |
|
2014
Q3 | $2.04M | Buy |
105,255
+23,255
| +28% | +$450K | 0.6% | 66 |
|
2014
Q2 | $2.79M | Buy |
82,000
+32,865
| +67% | +$1.12M | 0.83% | 42 |
|
2014
Q1 | $1.55M | Buy |
+49,135
| New | +$1.55M | 0.46% | 73 |
|